Marx, J. J. M.

Iron, Atherosclerosis, and Ischemic Heart Disease

de Valk, B., & Marx, J. J. M. (1999) · Archives of Internal Medicine

Iron Metabolism and DisordersAntioxidant Activity and Oxidative Stress

Cited by 250

Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo

Rooyakkers, T. M., Stroes, E. S. G., Kooistra, M. P., Van Faassen, E. E., Hider, R. C., Rabelink, T. J., & Marx, J. J. M. (2002) · European Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsIron Metabolism and Disorders

Cited by 157

Iron and infection: competition between host and microbes for a precious element

MARX, J. (2002) · Best Practice & Research Clinical Haematology

Iron Metabolism and DisordersHemoglobin structure and function

Cited by 129

Serum Ferritin Is a Risk Factor for Stroke in Postmenopausal Women

van der, D. L., Grobbee, D. E., Roest, M., Marx, J. J. M., Voorbij, H. A., & van der Schouw, Y. T. (2005) · Stroke

Iron Metabolism and DisordersAcute Ischemic Stroke Management

Cited by 107

Dietary haem iron and coronary heart disease in women

van der A, D. L., Peeters, P. H. M., Grobbee, D. E., Marx, J. J. M., & van der Schouw, Y. T. (2005) · European Heart Journal

Iron Metabolism and DisordersNutritional Studies and Diet

Cited by 78

Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A

Visseren, F. L. J., Verkerk, M. S. A., Van Der Bruggen, T., Marx, J. J. M., Van Asbeck, B. S., & Diepersloot, R. J. A. (2002) · European Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 64

Iron-Chelating Agents in Non-Iron Overload Conditions

Voest, E. E., Vreugdenhil, G., & Marx, J. J. M. (1994) · Annals of Internal Medicine

Iron Metabolism and DisordersTrace Elements in Health

Cited by 63

Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis

Georgiou, N. A., Van Der Bruggen, T., Oudshoorn, M., Hider, R. C., Marx, J. J. M., & Van Asbeck, B. S. (2002) · European Journal of Clinical Investigation

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 38